These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 8888810

  • 1. Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma.
    Iwafuchi M, Utsumi J, Tsuchida Y, Kaneko M, Matsuyama S, Ohnuma N, Taguchi N, Mugishima H, Yokoyama J, Sasaki S, Yoshioka A, Nagahara N, Fukuzawa M, Suita S.
    Med Pediatr Oncol; 1996 Dec; 27(6):515-20. PubMed ID: 8888810
    [Abstract] [Full Text] [Related]

  • 2. Neuroblastoma.
    Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [Abstract] [Full Text] [Related]

  • 3. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K, Fukuda M, Miyajima Y, Matsumoto K, Kondo M, Inaba J, Miyashita Y.
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [Abstract] [Full Text] [Related]

  • 4. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S, Tajiri T, Sera Y, Takamatsu H, Mizote H, Nagasaki A, Kurosaki N, Hara T, Okamura J, Miyazaki S, Sugimoto T, Kawakami K, Eguchi H, Tsuneyoshi M.
    J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.
    De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero Di Montezemolo L, Donfrancesco A, Pession A, Provenzi M, di Cataldo A, Rizzo A, Tonini GP, Dallorso S, Conte M, Gambini C, Garaventa A, Bonetti F, Zanazzo A, D'Angelo P, Bruzzi P, Italian Co-Operative Group for Neuroblastoma.
    J Clin Oncol; 2003 Apr 15; 21(8):1592-601. PubMed ID: 12697885
    [Abstract] [Full Text] [Related]

  • 9. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J, Filippa DA, Qin J, Wollner N.
    Cancer; 2003 Sep 15; 98(6):1283-91. PubMed ID: 12973853
    [Abstract] [Full Text] [Related]

  • 10. [Therapy of advanced neuroblastoma in children].
    Mutz I.
    Wien Med Wochenschr; 1982 Jul 31; 132(13-14):325-8. PubMed ID: 6182700
    [Abstract] [Full Text] [Related]

  • 11. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ.
    Med Pediatr Oncol; 2001 Jan 31; 36(1):227-30. PubMed ID: 11464891
    [Abstract] [Full Text] [Related]

  • 12. A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma.
    Garaventa A, Luksch R, Biasotti S, Severi G, Pizzitola MR, Viscardi E, Prete A, Mastrangelo S, Podda M, Haupt R, De Bernardi B.
    Cancer; 2003 Dec 01; 98(11):2488-94. PubMed ID: 14635085
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese Study Group for the Treatment of Advanced Neuroblastoma.
    Suita S, Zaizen Y, Kaneko M, Uchino J, Takeda T, Iwafuchi M, Utsumi J, Takahashi H, Yokoyama J, Nishihira H.
    J Pediatr Surg; 1994 Jun 01; 29(6):746-50. PubMed ID: 8078011
    [Abstract] [Full Text] [Related]

  • 15. Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol.
    Olgun N, Kansoy S, Aksoylar S, Cetingul N, Vergin C, Oniz H, Sarialioglu F, Kantar M, Uysal K, Tuncyurek M, Kargi A, Aktas S, Bayol U, Karaca I, Arikan A, Balik E, Aktug T, Elmas N, Kovanlikaya A, Kinay M, Anacak Y, Degirmenci B, Burak Z.
    Pediatr Hematol Oncol; 2003 Jun 01; 20(3):211-8. PubMed ID: 12637217
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
    Kuroda T, Morikawa N, Matsuoka K, Fujino A, Honna T, Nakagawa A, Kumagai M, Masaki H, Saeki M.
    J Pediatr Surg; 2008 Dec 01; 43(12):2182-5. PubMed ID: 19040931
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of advanced neuroblastoma by the protocol of the Welfare Ministry used by the Sawaguchi Group].
    Shida S, Arioka H, Hatayama Y, Nakadate H, Hatae Y, Takeda T.
    Gan To Kagaku Ryoho; 1988 Mar 01; 15(3):425-9. PubMed ID: 3348628
    [Abstract] [Full Text] [Related]

  • 20. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
    Valteau-Couanet D, Michon J, Boneu A, Rodary C, Perel Y, Bergeron C, Rubie H, Coze C, Plantaz D, Bernard F, Chastagner P, Bouzy J, Hartmann O.
    J Clin Oncol; 2005 Jan 20; 23(3):532-40. PubMed ID: 15659499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.